The DOI matches its Crossref record; 81 of the 83 references it cites were found in a registry or an index.
Interferon Consensus sequence-Binding Protein, a Member of the Interferon Regulatory Factor Family, Suppresses Interferon-Induced Gene Transcription
Open accessAbstract
We previously isolated a cDNA clone encoding interferon consensus sequence-binding protein (ICSBP), a member of the interferon regulatory factor (IRF) family, that binds to the interferon (IFN)-stimulated response element (ISRE) of many IFN-regulated genes. In this investigation, we studied the functional role of ICSBP by transient cotransfection of ICSBP cDNA with IFN-responsive reporter genes into the human embryonal carcinoma cell line N-Tera2. These cells were shown not to express ICSBP or IRF-2, thus allowing functional analysis of transfected cDNAs. Cotransfection of ICSBP into cells treated with retinoic acid or any of the IFNs (alpha, beta, or gamma) repressed expression of a chloramphenicol acetyltransferase reporter driven by the major histocompatibility complex class I gene promoter. Similarly, ICSBP repressed expression of chloramphenicol acetyltransferase reporters driven by the ISREs of the 2'-5' oligoadenylate synthetase, guanylate-binding protein, and ISG-15 genes in IFN-treated cells. The repression was dependent on the presence of the ISRE in the reporter. Deletion analysis showed that the putative N-terminal DNA binding domain of ICSBP by itself is capable of mediating the repression. Using the same cotransfection conditions as for ICSBP, a similar repression of these reporters was observed with IRF-2. Finally, ICSBP repressed the IRF-1-mediated induction of major histocompatibility complex class I and IFN-beta reporters in the absence of IFN or retinoic acid. Taken together, these results suggest that ICSBP is a negative regulatory factor capable of repressing transcription of target genes induced by IFN, retinoic acid, or IRF-1.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ICSBP/IRF8 is expressed exclusively in myeloid and B-cells (10)”
In the citing paper
“Likewise, previous reporter analysis indicated that ICSBP is a repressor of ISRE-dependent transcription (36, 57).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [36]
In the citing paper
“transfection of ICSBP alone reduced ISRE reporter activity by ∼ 40% irrespective of IFN𝛄 treatment, consistent with the previous finding that ICSBP represses ISRE-dependent transcription (36, 57).”
From Gamma Interferon Triggers Interaction between ICSBP (IRF-8) and TEL, Recruiting the Histone Deacetylase HDAC3 to the Interferon-Responsive Element (2002) · cites this paper as [36]
In the citing paper
“Subsequent studies have shown that ICSBP is a transcriptional repressor acting through the IFN-stimulated response element (ISRE). (6,20,21)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [20]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase
Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., & Erlich, H. A. (1988) · Science · doi:10.1126/science.2448875 · Cited by 17,719
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
Pestka, S., Langer, J. A., Zoon, K. C., & Samuel, C. E. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003455 · Cited by 1,826
Lymphokine Control of In Vivo Immunoglobulin Isotype Selection
Finkelman, F. D., Holmes, J. M., Katona, I. M., Urban, J. F., Beckmann, M. P., Park, L. S., Schooley, K., Coffman, R. L., Mosmann, T. R., & Paul, W. E. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.001511 · Cited by 1,301
Gorman, C. M., Merlino, G. T., Willingham, M. C., Pastan, I. H., & Howard, B. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6777 · Cited by 1,257
Stewart, W. E. (1979) · Springer eBooks · doi:10.1007/978-3-7091-3432-0 · Cited by 1,165
Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T., & Taniguchi, T. (1988) · Cell · doi:10.1016/s0092-8674(88)91307-4 · Cited by 971
Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T., & Taniguchi, T. (1989) · Cell · doi:10.1016/0092-8674(89)90107-4 · Cited by 957
Research works printed but not linked: 12
- 10.1128/mcb.10.10.5055-5063.1990 · DOI
- 10.1128/mcb.7.12.4498-4504.1987 · DOI
- 10.1016/0003-2697(87)90021-2 · DOI
- 10.1128/mcb.11.10.5147-5153.1991 · DOI
- 10.1128/mcb.12.8.3590-3599.1992 · DOI
- 10.1128/mcb.11.1.182-191.1991 · DOI
- 10.1128/mcb.12.1.1-9.1992 · DOI
- 10.1128/mcb.9.11.4605-4612.1989 · DOI
- 10.1128/mcb.10.6.2448-2457.1990 · DOI
- 10.1128/mcb.7.7.2625-2630.1987 · DOI
- 10.1128/mcb.12.8.3315-3324.1992 · DOI
- Weisz A. P. Marx R. Sharf E. Appella P. H. Driggers K. Ozato and B. Levi. The cloning and characterization of the human homologue of ICSBP that binds enhancer element common to interferon inducible genes. J. Biol. Chem. in press.
Cited by
Sorted by citations
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
CELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
IRF Family of Transcription Factors as Regulators of Host Defense
Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
“, 1989) and the IFN-consensus sequence-binding protein (ICSBP, also called IRF-8 ; Nelson et al., 1993), are known to bind ISREs and negatively regulate expression, and may help to prevent expression in the absence of IFN or down-regulate the induced response.”
BackgroundMethodHoltschke, T., Löhler, J., Kanno, Y., Fehr, T., Giese, N., Rosenbauer, F., Lou, J., Knobeloch, K.-P., Gabriele, L., Waring, J. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81348-3 · Cited by 644
Self-citationMatsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T. M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80086-8 · Cited by 649
Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 631
“ICSBP expression is restricted to the immune system and ICSBP can interact with both IRF-1 and IRF-2 at the ISRE to suppress IFN-inducible gene transcription (Driggers et al. 1992; Nelson et al. 1993; Bovolenta et al. 1994).”
BackgroundInterferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté-Génin, M., Servant, M. J., Page, C. L., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. B. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 576
The growing family of interferon regulatory factors
Nguyen, H., Hiscott, J., & Pitha, P. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00019-1 · Cited by 480
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
Au, W.-C., Moore, P. A., Lowther, W. J., Juang, Y., & Pitha, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11657 · Cited by 388
Regulation of Macrophage Chemokine Expression by Lipopolysaccharide In Vitro and In Vivo
Kopydlowski, K. M., Salkowski, C. A., Cody, M. J., van Rooijen, N., Major, J. A., Hamilton, T. A., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1537 · Cited by 315
Regulation of Type I Interferon Gene Expression by Interferon Regulatory Factor-3
Schafer, S. L., Lin, R., Moore, P. A., Hiscott, J. B., & Pitha, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2714 · Cited by 266
Kröger, A., Köster, M., Schroeder, K., Häuser, H., & Mueller, P. P. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452610 · Cited by 265
“(23,24,27) Although the heterodimerization of ICSBP with IRF-1 (and IRF-2) has been demonstrated, the mechanism of this repression is not understood.”
Brass, A. L., Kehrli, E., Eisenbeis, C. F., Storb, U., & Singh, H. (1996) · Genes & Development · doi:10.1101/gad.10.18.2335 · Cited by 242
Rehli, M., Poltorak, A., Schwarzfischer, L., Krause, S. W., Andreesen, R., & Beutler, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9773 · Cited by 233
Matsuyama, T., Grossman, A., Mittrücker, H.-W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., Taniguchi, T., Yoshinaga, S. K., & Mak, T. W. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2127 · Cited by 196
Interleukin‐4 and Interferon‐γ: The Quintessence of a Mutual Antagonistic Relationship
Paludan (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00435.x · Cited by 223
Scharton-Kersten, T., Contursi, C., Masumi, A., Sher, A., & Ozato, K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1523 · Cited by 217
Self-citationRoles of interferon-regulatory factors in T-helper-cell differentiation
Lohoff, M. D., & Mak, T. W. (2005) · Nature reviews. Immunology · doi:10.1038/nri1552 · Cited by 223
Burýšek, L., Yeow, W.-S., Lubyová, B., Kellum, M. J., Schafer, S. L., Huang, Y. Q., & Pitha, P. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7334-7342.1999 · Cited by 212
“presses the transactivation mediated by IRF-1 (33, 48, 53).”
BackgroundBrass, A. L., Zhu, A. Q., & Singh, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.977 · Cited by 204
“ICSBP is a lympho-myeloid-restricted repressor of interferon-inducible gene transcription (Driggers et al., 1990; Nelson et al., 1993).”
BackgroundThe Multiple Roles of Interferon Regulatory Factor family in Health and Disease
Wang, L., Zhu, Y., Zhang, N., Xian, Y., Tang, Y., Ye, J., Reza, F., He, G., Wen, X., & Jiang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01980-4 · Cited by 178
Yamagata, T., Nishida, J., Tanaka, T., Sakai, R., Mitani, K., Yoshida, M., Taniguchi, T., Yazaki, Y., & Hirai, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1283 · Cited by 196
Wang, I.-M., Contursi, C., Masumi, A., Ma, X., Trinchieri, G., & Ozato, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.271 · Cited by 187
“The finding that ICSBP activates IL-12 p40 promoter activity is contrary to its repressive function noted for a number of IFNabinducible promoters (18, 38).”
BackgroundMethodInfluentialSelf-citationReview: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells
Tamura, T., & Ozato, K. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452755 · Cited by 183
Self-citationKanno, Y., Kozak, C. A., Schindler, C., Driggers, P. H., Ennist, D. L., Gleason, S. L., Darnell, J. E., & Ozato, K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.3951 · Cited by 180
Self-citationLohoff, M. D., Duncan, G. S., Ferrick, D. A., Mittrücker, H., Bischof, S., Prechtl, S., Röllinghoff, M., Schmitt, E., Pahl, A. M., & Mak, T. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.325 · Cited by 174
Lubyová, B., & Pitha, P. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.8194-8201.2000 · Cited by 174
“Alignments of vIRF-3 and IRF-4 homologous regions are shown in Fig.”
InfluentialKaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor
Li, M., Lee, H., Guo, J., Neipel, F., Ozato, K., Jung, J. U., Fleckenstein, B., Jae, & Jung, U. (1997) · Cited by 171
Self-citationBovolenta, C., Driggers, P. H., Marks, M. S., Medin, J. A., Politis, A. D., Vogel, S. N., Levy, D. E., Sakaguchi, K., Appella, E., & Coligan, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.5046 · Cited by 167
Self-citationFehr, T., Schoedon, G., Odermatt, B., Holtschke, T., Schneemann, M., Bachmann, M. F., Mak, T. W., Horak, I., & Zinkernagel, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.921 · Cited by 162
Sharf, R., Meraro, D., Azriel, A., Thornton, A. M., Ozato, K., Petricoin, E. F., Larner, A. C., Schaper, F., Hauser, H., & Levi, B.-Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.15.9785 · Cited by 162
Self-citationGiese, N. A., Gabriele, L., Doherty, T. M., Klinman, D. M., Tadesse-Heath, L., Contursi, C., Epstein, S. L., & Morse, H. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1535 · Cited by 160
Jesse, T. L., LaChance, R., Iademarco, M. F., & Dean, D. C. (1998) · Journal of Cell Biology · doi:10.1083/jcb.140.5.1265 · Cited by 167
“(ICSBP is expressed only in macrophages and lymphocytes [Driggers et al., 1990; Nelson et al., 1993], and IGSF3 g is activated only in response to IFN treatment [Kessler et al., 1990].)”
Navarro, L., Mowen, K. A., Rodems, S. M., Weaver, B., Reich, N. C., Spector, D. H., & David, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3796 · Cited by 159
“Among them are several members of the IRF family (2, 6, 19, 30, 33, 51, 52) and the interferon consensus sequence binding protein ICSBP (22, 37).”
BackgroundRegulation of LMP2 and TAP1 Genes by IRF-1 Explains the Paucity of CD8+ T Cells in IRF-1−/− Mice
White, L. C., Wright, K. L., Felix, N. J., Ruffner, H., Reis, L. F. L., Pine, R. I., & Ting, J. P. ‐. (1996) · Immunity · doi:10.1016/s1074-7613(00)80262-9 · Cited by 157
Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor
Li, M., Lee, H., Guo, J., Neipel, F., Fleckenstein, B., Ozato, K., & Jung, J. U. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5433-5440.1998 · Cited by 151
Self-citationRegulation of MHC class I and II gene transcription: differences and similarities
van den Elsen, P. J., Gobin, S. J. P., van Eggermond, M. C. J. A., & Peijnenburg, A. (1998) · Immunogenetics · doi:10.1007/s002510050425 · Cited by 150
“1997), whereas IRF-2 and ICSBP act as repressors of MHC class I transcription (Fujita et al. 1989; Nelson et al. 1993).”
BackgroundInterferon regulatory factor family of transcription factors and regulation of oncogenesis
Takaoka, A., Tamura, T., & Taniguchi, T. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00720.x · Cited by 152
Kurotaki, D., Yamamoto, M., Nishiyama, A., Uno, K., Ban, T., Ichino, M., Sasaki, H., Matsunaga, S., Yoshinari, M., Ryo, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms5978 · Cited by 153
Self-citationMeraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147
Molecular virology of Kaposi's sarcoma–associated herpesvirus
Moore, P. S., & Chang, Y. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0777 · Cited by 147
Hao, S. X., & Ren, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1149-1161.2000 · Cited by 143
An overview of the interferon system: signal transduction and mechanisms of action.
Kalvakolanu, D., & Borden, E. (1996) · Cancer Investigation · doi:10.3109/07357909609018435 · Cited by 143
Sol, V. V., Punzón, C., & Fresno, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4461 · Cited by 138
“The IRF-8 expression vector (pUE5) and the corresponding empty vector (LK440), were a gift by Dr. K. Ozato (National Institutes of Health, Bethesda, MD) (47). pRL-TKluc (Promega), which express Renilla luciferase was used for determining transfection efficiency.”
Interleukin-10 Inhibits Tumor Metastasis, Downregulates MHC Class I, and Enhances NK Lysis
Kundu, N., & Fulton, A. M. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1176 · Cited by 141
Zhao, J., Kong, H. J., Li, H., Huang, B., Yang, M., Zhu, C. Y., Bogunovic, M., Zheng, F., Mayer, L., Ozato, K., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507788200 · Cited by 142
Self-citationKirchhoff, S., Schaper, F., & Häuser, H. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.12.2881 · Cited by 138
Zheng, S., De, B. P., Choudhary, S., Comhair, S. A. A., Goggans, T., Slee, R., Williams, B. R. G., Pilewski, J., Haque, S. J., & Erzurum, S. C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00114-6 · Cited by 125
Masumi, A., Wang, I.-M., Lefebvre, B., Yang, X.-J., Nakatani, Y., & Ozato, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1810 · Cited by 124
Self-citationIL-12 Is Dysregulated in Macrophages from IRF-1 and IRF-2 Knockout Mice
Salkowski, C. A., Kopydlowski, K., Blanco, J., Cody, M. J., McNally, R., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1529 · Cited by 119
Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding Protein
Gabriele, L., Phung, J., Fukumoto, J., Segal, D., Wang, I.-M., Giannakakou, P., Giese, N. A., Ozato, K., & Morse, H. C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.411 · Cited by 114
Self-citationLanford, R. E., Guerra, B., Lee, H., Chavez, D., Brasky, K. M., & Bigger, C. B. (2006) · Hepatology · doi:10.1002/hep.21167 · Cited by 114
Marecki, S., Riendeau, C. J., Liang, M. D., & Fenton, M. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6829 · Cited by 111
Alternate interferon signaling pathways
Kalvakolanu, D. V. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00070-6 · Cited by 109
Why Do So Many Cancer Patients Fail to Respond to Interferon Therapy?
Einhorn, S., & Grandér, D. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.275 · Cited by 101
Sharf, R., Azriel, A., Lejbkowicz, F., Winograd, S. S., Ehrlich, R., & Levi, B.-Z. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13063 · Cited by 100
Functional domains of interferon regulatory factor I (IRF-1)
Schaper, F., KIRCHHOFF, S., Posern, G., Köster, M., Oumard, A., Sharf, R., Levi, B.-Z., & Häuser, H. (1998) · Biochemical Journal · doi:10.1042/bj3350147 · Cited by 94
A unique palindromic element mediates gamma interferon induction of mig gene expression.
Wong, P., Severns, C. W., Guyer, N. B., & Wright, T. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.914 · Cited by 88
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87
IRF‐8/ICSBP and IRF‐1 cooperatively stimulate mouse IL‐12 promoter activity in macrophages
Masumi, A., Tamaoki, S., Wang, I., Ozato, K., & Komuro, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03556-1 · Cited by 87
Self-citationHimmelmann, A., Riva, A., Wilson, G. L., Lucas, B. P., Thevenin, C., & Kehrl, J. H. (1997) · Blood · doi:10.1182/blood.v90.10.3984 · Cited by 68
Barber, S. A., Fultz, M. J., Salkowski, C. A., & Vogel, S. N. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.601-608.1995 · Cited by 84
Type I interferons: expression and signalization
Doly, J., Civas, A., Navarro, S., & Uzé, G. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050240 · Cited by 82
IFN Regulatory Factor 3 in Health and Disease
Petro, T. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000462 · Cited by 77
Girdlestone, J., Isamat, M., Gewert, D. R., & Milstein, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11568 · Cited by 78
Horiuchi, M., Wakayama, K., Itoh, A., Kawai, K., Pleasure, D., Ozato, K., & Itoh, T. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-227 · Cited by 65
“response to LPS and IFNγ In BM-derived myeloid cells, IRF8 is critically involved in transcriptional regulation of various cytokines which are essential for initiation and modulation of the adaptive immune response [14,25,26].”
BackgroundSelf-citationMatikainen, S., Ronni, T., Lehtonen, A., Sareneva, T., Melén, K., Nordling, S., Levy, D. E., & Julkunen, I. (1997) · PubMed · Cited by 77
PU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74
“For example, both ICSBP and IRF-4 function as repressors when bound to ISRE elements (53,74).”
BackgroundGroß, I., Georgel, P., Kappler, C., Reichhart, J., & Hoffmann, J. A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.7.1238 · Cited by 76
Negative regulation of transcription in eukaryotes
Clark, A. R., & Docherty, K. (1993) · Biochemical Journal · doi:10.1042/bj2960521 · Cited by 76
Rosenbauer, F., Waring, J. F., Foerster, J., Wietstruk, M., Philipp, D., & Horak, I. (1999) · Blood · doi:10.1182/blood.v94.12.4274 · Cited by 76
Valente, A. J., Xie, J. F., Abramova, M. A., Wenzel, U. O., Abboud, H. E., & Graves, D. T. (1998) · PubMed · Cited by 74
Schaefer, B. C., Paulson, E. J., Strominger, J., & Speck, S. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.873 · Cited by 82
Contursi, C., Wang, I.-M., Gabriele, L., Gadina, M., O'Shea, J., Morse, H. C., & Ozato, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.91 · Cited by 72
Self-citationReview: ICSBP/IRF-8 Transactivation: A Tale of Protein-Protein Interaction
Levi, B.-Z., Hashmueli, S., Gleit-Kielmanowicz, M., Azriel, A., & Meraro, D. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452764 · Cited by 70
Kuwata, T., Gongora, C., Kanno, Y., Sakaguchi, K., Tamura, T., Kanno, T., Basrur, V., Martinez, R., Appella, E., Golub, T., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7439-7448.2002 · Cited by 69
“viously in nonimmune cells (36, 57), is relevant to activated”
BackgroundResultInfluentialSelf-citationA Complex Element Regulates IFN-γ-Stimulated Monocyte Chemoattractant Protein-1 Gene Transcription
Valente, A. J., Xie, J. F., Abramova, M. A., Wenzel, U. O., Abboud, H. E., & Graves, D. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3719 · Cited by 68
Review: The Role of IRF-4 in Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452737 · Cited by 68
“(5,27,31) The immunophilin FK506 binding protein 52 (FKBP52) was recently reported to interact with IRF-4 and induce a conformational change within the proline-rich domain, between aa 150 to 237, resulting in an inability to interact with PU.1 or to bind to DNA.”
Nagulapalli, S., & Atchison, M. L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4639 · Cited by 66
Xiong, H., Zhu, C. Y., Li, H., Chen, F., Mayer, L., Ozato, K., Unkeless, J. C., & Plevy, S. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209583200 · Cited by 64
Self-citationWang, I.-M., Blanco, J. C. G., Tsai, S. Y., Tsai, M.-J., & Ozato, K. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6313 · Cited by 64
Self-citationIRF8: Mechanism of Action and Health Implications
Moorman, H. R., Reategui-Almonacid, Y., Poschel, D. B., & Liu, K. (2022) · Cells · doi:10.3390/cells11172630 · Cited by 63
“repress transcription of genes induced by IFN and retinoic acid [72,73] or to activate target”
BackgroundReview: The Role of IRF-4 in B and T Cell Activation and Differentiation
Pernis, A. B. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452728 · Cited by 63
Regulation of IFN Consensus Sequence Binding Protein Expression in Murine Macrophages
Kantakamalakul, W., Politis, A. D., Marecki, S., Sullivan, T., Ozato, K., Fenton, M. J., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7417 · Cited by 61
Self-citationThe International Multiple Sclerosis Genetics Consortium (2011) · PLoS ONE · doi:10.1371/journal.pone.0018813 · Cited by 74
“expressed in cells of the immune system and responding to type 1 interferon stimulus [29].”
Interferon and Malignant Disease - How Does it Work and Why Doesn't it Always?
Grandér, D., & Einhorn, S. (1998) · Acta Oncologica · doi:10.1080/028418698430548 · Cited by 58
Huang, W., Horvath, E., & Eklund, E. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607760200 · Cited by 58
Megger, D. A., Philipp, J., Le‐Trilling, V. T. K., Sitek, B., & Trilling, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01139 · Cited by 56
Grant, C. E., Vasa, M. Z., & Deeley, R. G. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.12.2137 · Cited by 56
Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus
Cham, C. M., Ko, K., & Niewold, T. B. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/780436 · Cited by 55
Huang, W., Zhu, C., Wang, H., Horvath, E., & Eklund, E. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706710200 · Cited by 54
Molecular Characterization ofIn VivoAdjuvant Activity in Ferrets Vaccinated against Influenza Virus
Yuan, F., Rowe, T., Leon, A. J., Banner, D., Danesh, A., Xu, L., Ran, L., Bosinger, S. E., Guan, Y., Chen, H., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02305-09 · Cited by 52
Morin, P., Bragança, J., Bandu, M., Lin, R., Hiscott, J. B., Doly, J., & Civas, A. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5401 · Cited by 52
Konieczna, I. M., Horvath, E., Wang, H., Lindsey, S. C., Saberwal, G. S., Bei, L., Huang, W., Platanias, L. C., & Eklund, E. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33742 · Cited by 53
Flowers, C. C., Flowers, S. P., & Nabel, G. J. (1998) · Molecular Medicine · doi:10.1007/bf03401747 · Cited by 50
Deng, M., & Daley, G. Q. (2001) · Blood · doi:10.1182/blood.v97.11.3491 · Cited by 50
Au, W. C., Su, Y., Raj, N. B., & Pitha, P. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80488-8 · Cited by 50
Xi, H., Eason, D. D., Ghosh, D., Dovhey, S. E., Wright, K. L., & Blanck, G. (1999) · Oncogene · doi:10.1038/sj.onc.1202969 · Cited by 49
“The interferon regulatory factor (IRF) family is composed of several structurally related proteins including IRF-1 (Harada et al., 1989; Pine et al., 1990), IRF-2 (Harada et al., 1989), ICSBP (Nelson et al., 1993), ISGF3g (Veals et al., 1992), IRF-3 (Grant et al., 1995), IRF-7 (Zhang and Pagano, 1997), Pip (Eisenbeis…”
Metadata
- Authors
- Nelson, N., Marks, M. S., Driggers, P. H., & Ozato, K.
- Affiliations
- National Institutes of Health (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1993-01
- Volume
- 13
- Issue
- 1
- Pages
- 588-599
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC358938
- OpenAlex
- W1857506864
- Cited by
- 192
- References
- 83
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 2 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 2
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- IRF2, IRF1, interferon-stimulated response element, transcriptional repression, interferon-beta, retinoic acid, MHC class I, 2',5'-oligoadenylate synthetase, guanylate-binding proteins, DNA-binding domain, embryonal carcinoma cells
- MeSH terms
- Interferon Regulatory Factor-8, Base Sequence, Binding Sites, Carrier Proteins, Cells, Cultured, DNA-Binding Proteins, Enhancer Elements, Genetic, Gene Expression Regulation, Genes, MHC Class I, Humans, Interferons, Oligodeoxyribonucleotides, Phosphoproteins, Repressor Proteins, RNA, Messenger, Transcription Factors, Transcription, Genetic, Gene Expression, Polymerase Chain Reaction, Interferon-beta, Interferon Regulatory Factors, Interferon Regulatory Factor-2, Interferon Regulatory Factor-1, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review